Search Results for "President CEO Epicentre Biotechnologies"

08:30 EDT 30th May 2015 | BioPortfolio

Matching Channels

Drug Development for Rare Diseases

The economics of any industry relies on a large demand for a particular product; this applies to the pharmaceutical industry where efforts are focused on big and relatively straight-forward diseases...

Matching News

Liberia closes Ebola centre at epicentre of outbreak

Liberia's president on Monday announced the closure of an Ebola treatment facility which lay at the epicentre of the virus's worst outbreak in history, as the disease's spread has slowed in the countr...

ExpreS2ion Biotechnologies – production in Drosophila S2 cells

ExpreS2ion Biotechnologies is a world leading contract research organization (CRO) for the production in Drosophila Schneider-2 (S2) cells using its proprietary and complete S2 recombinant protein tec...

Adaptive Biotechnologies to purchase immunosequencing firm

Adaptive Biotechnologies said it secured $94 million in private equity funding and used the money to acquire Sequenta, an imm -More- 

THE CHARLOTTE OBSERVER FEATURES SEARCH SOLUTION GROUP ON THEIR BILLBOARD WIN AT THE EPICENTRE

CHARLOTTE, N.C., Dec. 17, 2014 (GLOBE NEWSWIRE) -- Search Solution Group®, an executive search and recruiting firm headquartered in Charlotte, N.C., will be featured today in The Charlotte Observer'...

Lion Biotechnologies Names Elma Hawkins President, Chief Executive Officer and Director

LOS ANGELES, Dec. 15, 2014 (GLOBE NEWSWIRE) -- Lion Biotechnologies, Inc., a biotechnology company that is developing novel cancer immunotherapies based on tumor infiltrating lymphocytes (TIL), today...

Minerva Biotechnologies Corp.

Minerva Biotechnologies Corp. is engaged in the development of novel biosensors.

Adaptive Biotechnologies Series F financing

Adaptive Biotechnologies announced the completion of Adaptive’s Series F financing round with a $195 million investment to support several strategic growth initiatives. This round was led by Matrix ...

Lion Biotechnologies seeks FDA's approval for trial of melanoma candidate

Lion Biotechnologies has submitted an application to the FDA for approval to initiate a midstage trial of its autologous T ce -More- 

Matching PubMed Articles

A New Initiative on Precision Medicine.

"Tonight, I'm launching a new Precision Medicine Initiative to bring us closer to curing diseases like cancer and diabetes - and to give all of us access to the personalized information we need to kee...

Introducing the New American Nurses Association President: Pamela F. Cipriano, PhD, RN, NEA-BC, FAAN.

This month in the Magnet® Perspectives column, Pamela F. Cipriano, PhD, RN, NEA-BC, FAAAN, new President of the American Nurses Association, discusses her priorities for the future and partnerships t...

Camelid Genetics and Reproductive Biotechnologies.

Minutes of the General Assembly in Amsterdam, Wednesday, June 25th 2014, 15.30-16.15.

1) Welcome from the Congress President 2) The Minutes of the General Assembly of Toulouse, published in the Rhinology Journal of June 2013 are accepted. 3) Report of President 4) Report of General Sec...

Epidemiology, Ecology and Gene Pool of Influenza A Virus in Egypt: Will Egypt be the Epicentre of the Next Influenza Pandemic?

Abstract Outside Asia, Egypt is considered to be an influenza H5N1 epicentre and presents a far greater pandemic risk than other countries. The long-term endemicity of H5N1 and the recent emergence of...

Search Whole site using Google

Loading
Search BioPortfolio:
Loading
Advertisement
Advertisement
Advertisement Advertisement